AM-2201 4-methoxynaphthyl analogue
Limited data
Limited data
Sparse data. Doses and effects may be unreliable or untested.
- 1 source
- no dose data
Limited data
Sparse data. Doses and effects may be unreliable or untested.
- 1 source
- no dose data
Summary
A naphthoylindole synthetic cannabinoid: AM-2201 with a methoxy group on the naphthalene ring, acting as a CB1/CB2 receptor agonist. A previous version of this page called it "a depressant opioid" — that text was generated from a wrong classification, not from any source. No human data exists for this analogue; the risks of its chemotype, documented for close relatives like AM-2201, are racing heart, hypertension, vomiting and seizures rather than opioid-type respiratory depression.
Effects
AM-2201 4-methoxynaphthyl analogue's nerd page
Pharmacology, chemical data, effect profiles, and more
→
Helpful Links
Report an issue or suggest an edit
Spotted incorrect or dangerous information, have a correction, a new study, or a useful addition for AM-2201 4-methoxynaphthyl analogue? Let us know. Reports are reviewed by moderators — this is not posted publicly.